Cybin Inc (CYBN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYBN | BMY | AMGN | GILD | REGN |
| Company | Cybin Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.3589 | 49.03 | 271.26 | 66.47 | 905.66 |
| High | 0.3589 | 49.03 | 271.26 | 66.47 | 912.74 |
| Low | 0.3589 | 49.03 | 271.26 | 66.47 | 903.83 |
| Last | 0.3589 | 49.03 | 271.26 | 66.47 | 907.32 |
| Change | +0.0039 | +0.04 | -2.28 | -0.56 | +7.16 |
| % Change | +1.10% | +0.08% | -0.83% | -0.84% | +0.80% |
| Volume | 25,118 | 17,442 | 9,660 | 20,338 | 341,200 |
| 20-Day Average Volume | 4,082,831 | 10,457,127 | 2,049,833 | 6,068,202 | 442,475 |
| Previous Close | 0.3550 | 48.99 | 273.54 | 67.03 | 900.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3967 | 50.38 | 271.46 | 69.04 | 929.14 |
| 20-Day Raw Stochastic | 6.41% | 20.63% | 37.94% | 7.15% | 19.57% |
| 20-Day Relative Strength | 43.31% | 41.96% | 46.57% | 31.26% | 39.70% |
| Weighted Alpha | -31.87 | -25.66 | +10.17 | -21.77 | +14.00 |
| Today's Opinion | 72% Sell | 88% Sell | 72% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 72% Sell | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 24% Buy | 8% Sell | 24% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.40% since 04/17/24 | +2.49% since 04/17/24 | +2.72% since 04/17/24 | -0.69% since 04/17/24 | +1.47% since 04/16/24 |
| Low | 0.3513 on 04/23/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 891.46 on 04/19/24 |
| High | 0.3800 on 04/22/24 | 49.56 on 04/22/24 | 274.48 on 04/23/24 | 67.68 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | -14.02% since 03/22/24 | -5.58% since 03/22/24 | -1.78% since 03/22/24 | -8.46% since 03/22/24 | -6.19% since 03/22/24 |
| Low | 0.3513 on 04/23/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 0.4699 on 04/03/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | -2.47% since 01/24/24 | -2.41% since 01/24/24 | -11.21% since 01/24/24 | -16.42% since 01/24/24 | -4.95% since 01/23/24 |
| Low | 0.2831 on 02/07/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 0.5224 on 03/13/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -18.52% since 10/24/23 | -12.63% since 10/24/23 | -1.76% since 10/24/23 | -14.95% since 10/24/23 | +14.05% since 10/23/23 |
| Low | 0.2831 on 02/07/24 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 0.7380 on 10/31/23 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 145,854 | 99,290,928 | 146,720,288 | 83,457,512 | 99,589,264 |
| Shares Outstanding, K | 410,855 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -35,930,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 0 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -22,270,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 0.43 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 02/14/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 02/13/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.55 | 14.58 | 9.96 | 23.95 |